Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinoma

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 819-825

  Brockmann, Jens G ^a,d   Hernandez, Carlos A ^b   Emparan, Carlos ^c   Wolters, Heiner ^a   Haier, Jörg ^a   Dietl, Karl Heinz ^a   Senninger, Norbert J ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bilio pancreatic carcinoma; TAP; Tumor marker

Indexed keywords

TRYPSINOGEN ACTIVATION PEPTIDE;

ADULT; AGED; BILE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GALLBLADDER; GALLBLADDER CARCINOMA; GASTROINTESTINAL CARCINOMA; HUMAN; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

BILE; BILE DUCT NEOPLASMS; BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; HUMANS; MIDDLE AGED; OLIGOPEPTIDES; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; REFERENCE VALUES; TRYPSINOGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0038199735     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Neurath H: Evolution of proteolytic enzymes. Science 224(4647): 350-7, 1984.
2. Koshikawa N, Hasegawa S, Nagashima Y, Mitsuhashi K, Tsubota Y, Miyata S, Miyagi Y, Yasumitsu H and Miyazaki K: Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol 153(3): 937-44, 1998.
3. Terada T, Ohta T, Minato H and Nakanuma Y: Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 26(7): 746-52, 1995.
4. Emi M, Nakamura Y, Ogawa M, Yamamoto T, Nishide T, Mori T and Matsubara K: Cloning, characterization and nucleotide sequences of two CDNAs encoding human pancreatic trypsinogens. Gene 41(2-3): 305-10, 1986.
5. Tani T, Kawashima I, Mita, K and Takiguchi Y: nucleotide sequence of the human pancreatic trypsinogen III CDNA. Nucleic Acids Res 18(6): 1631, 1990.
6. Wiegand U, Corbach S, Minn A, Kang J and Muller-Hill B: Cloning of the CDNA encoding human brain trypsinogen and characterization of its product. Gene 136(1-2): 167-75, 1993.
7. Scheele G, Bartelt D and Bieger W: Characterization of human exocrine pancreatic proteins by two-dimensional Isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Gastroenterology 80(3): 461-73, 1981.
8. Kemppainen E, Hedstrom J, Puolakkainen P, Halttunen J, Sainio V, Haapiainen R, Kivilaakso E and Stenman UH: Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy [See Comments]. Gut 41(5): 690-5, 1997.
9. Hedstrom J, Sainio V, Kemppainen E, Haapiainen R, Kivilaakso E, Schroder T, Leinonen J and Stenman UH: Serum complex of trypsin 2 and alpha 1 Antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients [See Comments]. BMJ 1313(7053): 333-7, 1996.
10. Sainio V, Puolakkainen P, Kemppainen E, Hedstrom J, Haapiainen R, Kivisaari L, Stenman UH, Schroder T and Kivilaakso E: Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 31(8): 818-24, 1996.
11. Hedstrom J, Sainio V, Kemppainen E, Puolakkainen P, Haapiainen R, Kivilaakso E, Schauman KO and Stenman UH: Urine trypsinogen-2 as marker of acute pancreatitis. Clin Chem 42(5): 685-90, 1996.
12. Nguyen TD, Moody MW, Steinhoff M, Okolo C, Koh DS and Bunnett NW: Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2. J Clin Invest 103(2): 261-9, 1999.
13. Hartwig W, Werner J, Jimenez RE, Z'graggen K, Weimann J, Lewandrowski KB, Warshaw AL and Fernandez-del Castillo C: Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury. Am J Physiol 277(5 Pt 1): G1008-G1016, 1999.
14. Tryggvason K, Hoyhtya M and Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907(3): 191-217, 1987.
15. Chen WT: Membrane proteases: roles in tissue remodeling and tumour invasion. Curr Opin Cell Biol 4(5): 802-9, 1992.
16. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9(4): 289-303, 1990.
17. Quigley JP, Berkenpas MB, Aimes RT and Chen JM: Serine protease and metallo protease cascade systems involved in pericellular proteolysis. Cell Differ Dev 32(3): 263-75, 1990.
18. Stenman UH: Tumour-associated trypsin inhibitor and tumour-associated trypsin. Scand J Clin Lab Invest Suppl 201: 93-101, 1990.
19. Koshikawa N, Yasumitsu H, Umeda M and Miyazaki K: Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res 52(18): 5046-53, 1992.
20. Kato Y, Nagashima Y, Koshikawa N, Miyagi Y, Yasumitsu H and Miyazaki K: Production of trypsins by human gastric cancer cells correlates with their malignant phenotype. Eur J Cancer 34(7): 1117-23, 1998.
21. Miyata S, Koshikawa N, Higashi S, Miyagi Y, Nagashima Y, Yanoma S, Kato Y, Yasumitsu H and Miyazaki K: Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of alzheimer amyloid precursor protein in culture. J Biochem (Tokyo) 125(6): 1067-76, 1999.
22. Hirahara F, Miyagi Y, Miyagi E, Yasumitsu H, Koshikawa N, Nagashima Y, Kitamura H, Minaguchi H, Umeda M and Miyazaki K: Trypsinogen expression in human ovarian carcinomas. Int J Cancer 63(2): 176-81, 1995.
23. Huhtala ML, Pesonen K, Kalkkinen N and Stenman UH: Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 257(22): 13713-6, 1982.
24. Koivunen E, Itkonen O, Halila H and Stenman UH: Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. Cancer Res 50(8): 2375-8, 1990.
25. Koivunen E, Huhtala ML and Stenman UH: Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of prourokinase. J Biol Chem 264(24): 14095-9, 1989.
26. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K and Kitamura H: Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 28(5): 613-22, 1997.
27. Koivunen E, Saksela O, Itkonen O, Osman S, Huhtala ML and Stenman UH: Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer 47(4): 592-6, 1991.
28. Bernard-Perrone F, Carrere J, Renaud W, Moriscot C, Thoreux K, Bernard P, Servin A, Balas D and Senegas-Balas F: Pancreatic trypsinogen I expression during cell growth and differentiation of two human colon carcinoma cells. Am J Physiol 274(6 Pt 1): G1077-G1086, 1998.
29. Miszczuk-Jamska B, Merten M, Guy-Crotte O, Amouric M, Clemente F, Schoumacher RA and Figarella C: Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1. FEBS Lett 294(3): 175-8, 1991.
30. Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, Fonseca L and Miyazaki I: Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Br J Cancer 69(1): 152-6, 1994
31. Hedstrom J, Haglund C, Haapiainen R and Stenman UH: Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases, preferential elevation in patients with cholangiocarcinomas. Int J Cancer 66(3): 326-31, 1996.
32. Hedstrom J, Haglund, C, Kemppainen E, Leinimaa M, Leinonen J and Stenman UH: Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancer. Clin Chem 45(10): 1768-73, 1999.
33. Stenman UH, Koivunen E and Itkonen O: Biology and function of tumor-associated trypsin inhibitor, TATI. Scand J Clin Lab Invest Suppl 207: 5-9, 1991.
34. Fujimura T, Ohta T, Kitagawa H, Fushida S, Nishimura GI, Yonemura Y, Elnemr A, Miwa K and Nakanuma Y: Trypsinogen expression and early detection for peritoneal dissemination in gastric cancer. J Surg Oncol 69(2): 71-5, 1998.
35. Koshikawa N, Nagashima Y, Miyagi Y, Mizushima H, Yanoma S, Yasumitsu H and Miyazaki K: Expression of trypsin in vascular endothelial cells. FEBS Lett 409(3): 442-8, 1997.
36. Whitcomb DC: Early trypsinogen activation in acute pancreatitis. Gastroenterology 116(3): 770-2, 1999.
37. Otani T, Chepilko SM, Grendell JH and Gorelick FS: Codistribution of TAP and the granule membrane protein GRAMP-92 in rat caerulein-induced pancreatitis. Am J Physiol 275(5 Pt 1): G999-G1009, 1998.
38. Hofbauer B, Saluja AK, Lerch MM, Bhagat L, Bhatia M, Lee HS, Frossard JL, Adler G and Steer, ML: Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol 275(2 Pt 1): G352-G362, 1998.
39. Saluja AK, Donovan EA, Yamanaka K, Yamaguchi Y, Hofbauer B and Steer ML: Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113(1): 304-10, 1997.
40. Grady T, Mah'Moud M, Otani T, Rhee S, Lerch MM and Gorelick FS: Zymogen proteolysis within the pancreatic acinar cell is associated with cellular injury. Am J Physiol 275(5 Pt 1): G1010-G1017, 1998.
41. Gudgeon AM, Heath DI, Hurley P, Jehanli, A, Patel G, Wilson C, Shenkin A, Austen BM, Imrie CW and Hermon-Taylor J: Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 335(8680): 4-8, 1990.
42. Tenner S, Fernandez-del, Castillo C, Warshaw A, Steinberg W, Hermon-Taylor J, Valenzuela, JE, Hariri M, Hughes M and Banks PA: Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 21(2): 105-10, 1997.
43. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ and Modlin I: Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference. Int J Pancreatol 25(3): 195-210, 1999.
44. Mithofer K, Fernandez-del Castillo C, Rattner D and Warshaw AL: Subcellular kinetics of early trypsinogen activation in acute rodent pancreatitis. Am J Physiol 274(1 Pt 1): G71-G79, 1998.
45. Brockmann J, Glodny B, Hofknecht S and Senninger N: Tumor-marker im gallenblasensaft als mittel zur identifizierung bilio-pankreatischer karzinome. Anticancer Res 19(6D): 5679, 1999.
46. Brockmann J, Glodny B, Menzel J, Winde G and Senninger N: Quantificating expression of tumor markers in gallbladder bile for identification of malignancies of the subhepatic bilio-pancreatic system. Langenbecks Forumband 1999: 307-13, 1999.
47. Hurley PR, Cook A, Jehanli A, Austen BM and Hermon-Taylor J: Development of radioimmunoassays for free tetra-l-aspartyl-l-lysine trypsinogen activation peptides (TAP). J Immunol Methods 111(2): 195-203, 1988.
48. Grant DA, Talbot RW and Hermon-Taylor J: Catalytically active enterokinase in human bile. Clin Chim Acta 142(1): 39-45, 1984.
49. Grant DA, Jones PA, Magee AI and Hermon-Taylor J: The biliary excretion of intravenously administered enterokinase [proceedings]. Biochem Soc Trans 8(1): 55, 1980.
50. Grant DA, Terry TR and Hermon-Taylor J: Biliary excretion of enterokinase in rats: studies in alcoholic rats with fatty liver. Gut 24(1): 16-9, 1983.
51. Talbot RW, Grant DA and Hermon-Taylor J: Displacement of endogenous enterokinase into portal venous blood and bile following luminal perfusion of proximal small intestine in guinea pigs. Dig Dis Sci 29(11): 1009-14, 1984.
52. Sorsa T, Salo T, Koivunen E, Tyynela J, Konttinen YT, Bergmann U, Tuuttila A, Niemi E, Teronen O, Heikkila P, Tschesche H, Leinonen J, Osman S and Stenman UH: Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 272(34): 21067-74, 1997.
53. Aimes RT and Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270(11): 5872-6, 1995.